Evidence map›Paper›PMID 21192729›Full record

ArticleAnalytical chemistry2011

Screening natural products for inhibitors of quinone reductase-2 using ultrafiltration LC-MS.

Yongsoo Choi, Katherine Jermihov, Sang-Jip Nam, Megan Sturdy, Katherine Maloney, Xi Qiu, Lucas R Chadwick, Matthew Main, Shao-Nong Chen, Andrew D Mesecar and 6 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Review
  3. Potential Multifunctional Bioactive Compounds fromJournal of inflammation research · 2022
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

  • Erratum issued
    van Breemen, Richard R [corrected to van Breemen, Richard B]
5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Yongsoo ChoiDepartment of Medicinal Chemistry and Pharmacognosy, University of Illinois College of Pharmacy, Chicago, Illinois 60612, USA.
Katherine Jermihov
Sang-Jip Nam
Megan Sturdy
Katherine Maloney
Xi Qiu
Lucas R Chadwick
Matthew Main
Shao-Nong Chen
Andrew D Mesecar
Norman R Farnsworth
Guido F Pauli
William Fenical
John M Pezzuto
Richard B van Breemen
Richard R van Breemen
University of Illinois Urbana-Champaign · USIllinois College · USScripps Institution of Oceanography · USPurdue University West Lafayette · USUniversity of Illinois Chicago · USUniversity of Hawaii at Hilo · US

Funding

Van Breemen: Project 3; Botanical Dietary Supplements - Metabolism and Safety in Women (Van Breemen)P50AT000155 · NCCIH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PAULI, GUIDO F · 1999 to 2019
$30.4M
Structural BiologyP01CA048112 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PEZZUTO, JOHN M. · 1991 to 2009
$12.4M
UCSD Cancer Center Training Program in Drug DevelopmentT32CA121938 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Michael Bouvet, Dwayne G. Stupack · 2006 to 2026
$10.3M
Antitumor-Antibiotics from Marine MicroorganismsR37CA044848 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FENICAL, WILLIAM · 2004 to 2013
$3.9M
HPLC time-of-flight mass spectrometer for accurate mass measurementsS10RR023785 · NCRR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI VAN BREEMEN, RICHARD B · 2007 to 2007
$290k
NCCIH NIH HHS P50 AT000155NCCIH NIH HHS P50 AT00155NCI NIH HHS P01 CA048112NCI NIH HHS P01 CA48112NCI NIH HHS R37 CA044848NCI NIH HHS T32 CA121938NCRR NIH HHS S10 RR023785
6 · The paper itself

Abstract

Inhibitors of quinone reductase-2 (NQO2; QR-2) can have antimalarial activity and antitumor activities or can function as chemoprevention agents by preventing the metabolic activation of toxic quinones such as menadione. To expedite the search for new natural product inhibitors of QR-2, we developed a screening assay based on ultrafiltration liquid chromatography-mass spectrometry that is compatible with complex samples such as bacterial or botanical extracts. Human QR-2 was prepared recombinantly, and the known QR-2 inhibitor, resveratrol, was used as a positive control and as a competitive ligand to eliminate false positives. Ultrafiltration LC-MS screening of extracts of marine sediment bacteria resulted in the discovery of tetrangulol methyl ether as an inhibitor of QR-2. When applied to the screening of hop extracts from the botanical, Humulus lupulus L., xanthohumol and xanthohumol D were identified as ligands of QR-2. Inhibition of QR-2 by these ligands was confirmed using a functional enzyme assay. Furthermore, binding of xanthohumol and xanthohumol D to the active site of QR-2 was confirmed using X-ray crystallography. Ultrafiltration LC-MS was shown to be a useful assay for the discovery of inhibitors of QR-2 in complex matrixes such as extracts of bacteria and botanicals.

Indexed as

Biological ProductsChromatography, LiquidCrystallography, X-RayDrug Evaluation, PreclinicalEnzyme InhibitorsFiltrationFlavonoidsHumansHumulusMass SpectrometryModels, MolecularMolecular StructureNAD(P)H Dehydrogenase (Quinone)PropiophenonesBiological ProductsEnzyme InhibitorsFlavonoidsNAD(P)H Dehydrogenase (Quinone)Propiophenonesxanthohumolxanthohumol D

Identifiers

PMID21192729
PMCPMC3034444
OpenAlexW2024211702

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.